- Book
- October 2023
- 576 Pages
- Book
- April 2022
- 240 Pages
- Book
- May 2021
- 512 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2019
- 632 Pages
- Book
- April 2018
- 776 Pages
United States
- Book
- January 2016
- 368 Pages
- Book
- April 2015
- 456 Pages
- Book
- May 2014
- 616 Pages
- Book
- May 2013
- 400 Pages
- Book
- April 2013
- 294 Pages
- Book
- July 2012
- 448 Pages
- Book
- November 2010
- 456 Pages
- Book
- October 2010
- 454 Pages
- Book
- September 2010
- 448 Pages
- Book
- March 2010
- 512 Pages
- Book
- December 2020
Global

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more